Free Trial
→ Elon’s AI supercomputer just went live. Here’s my #1 stock. (From InvestorPlace) (Ad)tc pixel Free CTS Stock Alerts

CTS (CTS) Financials

CTS logo
$59.84 -0.17 (-0.28%)
Closing price 05/7/2026 03:59 PM Eastern
Extended Trading
$59.84 0.00 (0.00%)
As of 05/7/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for CTS

Annual Income Statements for CTS

This table shows CTS's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 6.95 34 14 47 36 35 -42 60 61 55 65
Consolidated Net Income / (Loss)		 6.95 34 14 47 36 35 -42 60 61 55 65
Net Income / (Loss) Continuing Operations		 6.95 34 14 47 36 35 -42 60 61 55 65
Total Pre-Tax Income 		12 57 40 58 50 45 -61 81 75 69 84
Total Operating Income		 18 63 38 61 54 45 76 93 75 71 83
Total Gross Profit		 127 140 140 165 158 139 185 211 191 188 208
Total Revenue		 382 397 423 470 469 424 513 587 550 515 541
Operating Revenue		 382 397 423 470 469 424 513 587 550 515 541
Total Cost of Revenue		 255 256 283 306 311 285 328 376 360 327 333
Operating Cost of Revenue		 255 256 283 306 311 285 328 376 360 327 333
Total Operating Expenses		 109 77 102 104 104 94 108 118 116 116 125
Selling, General & Admin Expense		 60 62 72 74 70 68 83 92 84 88 99
Research & Development Expense		 22 24 25 25 26 24 24 24 25 23 25
Restructuring Charge		 15 3.05 4.14 5.06 7.45 1.83 1.69 1.91 7.07 4.70 1.40
Total Other Income / (Expense), net		 -5.85 -5.92 1.76 -2.94 -3.55 0.35 -137 -12 0.10 -2.60 1.13
Interest Expense		 2.63 3.70 3.34 2.09 2.65 3.27 2.11 2.19 3.33 4.24 4.31
Interest & Investment Income		 3.07 1.31 1.28 1.83 1.74 1.05 0.84 1.33 4.63 4.28 2.13
Other Income / (Expense), net		 -6.30 -3.52 3.82 -2.68 -2.64 2.58 -136 -11 -1.19 -2.65 3.30
Income Tax Expense		 5.31 23 26 12 14 11 -19 21 15 13 18
Basic Earnings per Share		 $0.21 $1.05 $0.44 $1.41 $1.11 $1.07 ($1.30) $1.86 $1.93 $1.82 $2.21
Weighted Average Basic Shares Outstanding		 32.96M 32.73M 32.89M 33.02M 32.70M 32.32M 32.33M 31.97M 31.36M 30.41M 29.51M
Diluted Earnings per Share		 $0.21 $1.03 $0.43 $1.39 $1.09 $1.06 ($1.30) $1.85 $1.92 $1.81 $2.19
Weighted Average Diluted Shares Outstanding		 33.48M 33.25M 33.42M 33.57M 33.11M 32.58M 32.33M 32.24M 31.58M 30.72M 29.81M
Weighted Average Basic & Diluted Shares Outstanding		 33.10M 32.70M 32.80M 33M 64.87M 32.35M 32.15M 31.67M 30.79M 30.04M 28.70M
Cash Dividends to Common per Share		 $0.16 $0.16 $0.16 $0.16 $0.16 $0.16 $0.16 $0.16 $0.16 $0.16 $0.16

Quarterly Income Statements for CTS

This table shows CTS's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 14 15 11 15 18 14 13 19 14 20 17
Consolidated Net Income / (Loss)		 14 15 11 15 18 14 13 19 14 20 17
Net Income / (Loss) Continuing Operations		 14 15 11 15 18 14 13 19 14 20 17
Total Pre-Tax Income 		19 18 14 18 22 17 16 23 20 25 22
Total Operating Income		 18 16 15 18 21 19 16 23 21 23 22
Total Gross Profit		 46 42 45 46 49 48 47 52 55 54 55
Total Revenue		 135 125 126 130 132 127 126 135 143 137 139
Operating Revenue		 135 125 126 130 132 127 126 135 143 137 139
Total Cost of Revenue		 88 83 81 84 83 80 79 83 88 84 84
Operating Cost of Revenue		 88 83 81 84 83 80 79 83 88 84 84
Total Operating Expenses		 28 26 31 29 28 29 30 30 34 31 33
Selling, General & Admin Expense		 19 19 22 21 23 22 24 23 27 25 26
Research & Development Expense		 6.32 5.29 6.60 6.09 5.03 5.67 6.19 6.33 6.90 5.85 6.63
Restructuring Charge		 3.23 1.04 1.69 1.19 0.77 1.04 0.45 0.30 0.28 0.37 0.39
Total Other Income / (Expense), net		 0.55 1.37 -0.88 0.01 0.97 -1.66 -0.16 0.25 -1.22 2.26 -0.31
Interest Expense		 1.00 0.82 0.80 0.83 1.31 1.30 1.17 1.12 1.11 0.91 0.71
Interest & Investment Income		 0.95 1.54 1.39 1.44 0.97 0.48 0.45 0.62 0.54 0.53 0.48
Other Income / (Expense), net		 0.59 0.66 -1.46 -0.60 1.31 -0.84 0.56 0.75 -0.64 2.64 -0.08
Income Tax Expense		 4.77 2.31 2.54 3.06 3.76 3.74 2.76 4.46 6.03 5.21 4.48
Basic Earnings per Share		 $0.45 $0.49 $0.36 $0.48 $0.60 $0.45 $0.45 $0.62 $0.47 $0.67 $0.60
Weighted Average Basic Shares Outstanding		 31.30M 31.36M 30.74M 30.51M 30.30M 30.41M 30.01M 29.74M 29.35M 29.51M 28.69M
Diluted Earnings per Share		 $0.44 $0.49 $0.36 $0.48 $0.59 $0.44 $0.44 $0.62 $0.46 $0.67 $0.59
Weighted Average Diluted Shares Outstanding		 31.51M 31.58M 30.99M 30.73M 30.54M 30.72M 30.33M 29.99M 29.63M 29.81M 29.00M
Weighted Average Basic & Diluted Shares Outstanding		 31.16M 30.79M 30.57M 30.37M 30.12M 30.04M 29.84M 29.48M 29.05M 28.70M 28.59M
Cash Dividends to Common per Share		 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04

Annual Cash Flow Statements for CTS

This table details how cash moves in and out of CTS's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 22 -43 -0.23 -13 -0.69 -8.47 50 15 6.97 -70 -12
Net Cash From Operating Activities		 39 47 58 58 64 77 86 121 89 98 102
Net Cash From Continuing Operating Activities		 39 47 58 58 64 77 86 121 89 98 102
Net Income / (Loss) Continuing Operations		 6.95 34 14 47 36 35 -42 60 61 55 65
Consolidated Net Income / (Loss)		 6.95 34 14 47 36 35 -42 60 61 55 65
Depreciation Expense		 16 19 21 23 25 27 27 30 29 31 35
Non-Cash Adjustments To Reconcile Net Income		 24 -8.75 17 5.60 8.11 8.77 140 11 3.23 12 2.94
Changes in Operating Assets and Liabilities, net		 -5.47 4.18 6.37 -16 -4.47 6.65 -39 21 -3.66 0.23 -0.69
Net Cash From Investing Activities		 -9.13 -81 -37 -28 -96 -23 -16 -111 -18 -141 -19
Net Cash From Continuing Investing Activities		 -9.13 -81 -37 -28 -96 -23 -16 -111 -18 -141 -19
Purchase of Property, Plant & Equipment		 -9.72 -21 -18 -28 -22 -15 -16 -14 -15 -19 -16
Acquisitions		 -1.29 -73 -19 0.00 -74 -8.31 -0.26 -97 -3.36 -122 0.00
Purchase of Investments		 - - - - - - - - 0.00 0.00 -2.78
Net Cash From Financing Activities		 -7.83 -8.64 -21 -42 30 -61 -21 4.34 -65 -27 -98
Net Cash From Continuing Financing Activities		 -7.83 -8.64 -21 -42 30 -61 -21 4.34 -65 -27 -98
Repayment of Debt		 -1,344 -2,458 -1,519 -1,060 -1,886 -3,793 -809 -723 -775 -891 -1,138
Repurchase of Common Equity		 -18 0.00 0.00 -9.44 -12 -8.08 -8.79 -21 -41 -43 -56
Payment of Dividends		 -5.29 -5.23 -5.26 -5.29 -5.24 -5.18 -5.17 -5.13 -5.04 -4.89 -4.75
Issuance of Debt		 1,359 2,457 1,505 1,034 1,936 3,747 804 757 758 916 1,104
Other Financing Activities, net		 -0.15 -1.81 -1.60 -1.47 -2.66 -2.97 -2.15 -2.72 -3.26 -4.21 -2.71
Effect of Exchange Rate Changes		 0.23 -0.42 -0.79 0.19 0.35 -0.75 0.16 1.10 1.65 -0.34 2.81
Cash Interest Paid		 2.42 2.94 2.13 1.58 1.96 2.60 1.95 2.02 3.13 4.23 4.00
Cash Income Taxes Paid		 6.78 10 11 9.92 11 12 17 20 20 17 17

Quarterly Cash Flow Statements for CTS

This table details how cash moves in and out of CTS's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 9.23 3.76 -1.45 -1.18 -66 -0.54 -4.05 9.15 11 -28 8.56
Net Cash From Operating Activities		 22 32 18 20 35 26 16 28 29 29 17
Net Cash From Continuing Operating Activities		 22 32 18 20 35 26 16 28 29 29 17
Net Income / (Loss) Continuing Operations		 14 15 11 15 19 14 13 19 14 20 17
Consolidated Net Income / (Loss)		 14 15 11 15 19 14 13 19 14 20 17
Depreciation Expense		 7.25 7.29 7.33 7.33 7.99 8.28 8.49 8.55 8.84 8.66 8.81
Non-Cash Adjustments To Reconcile Net Income		 -3.37 1.68 2.14 0.29 4.74 4.45 2.31 1.37 -0.57 -0.17 -5.07
Changes in Operating Assets and Liabilities, net		 4.28 7.78 -2.27 -2.70 3.99 -0.38 -8.65 -0.09 7.07 0.98 -3.64
Net Cash From Investing Activities		 -2.75 -3.50 -4.04 -4.64 -126 -6.10 -4.47 -3.28 -4.80 -5.97 -2.11
Net Cash From Continuing Investing Activities		 -2.75 -3.50 -4.04 -4.64 -126 -6.10 -4.47 -3.28 -4.80 -5.97 -2.11
Purchase of Property, Plant & Equipment		 -2.75 -3.50 -4.04 -4.64 -3.87 -6.10 -4.47 -3.28 -4.80 -3.19 -5.00
Acquisitions		 - - 0.00 - -122 - 0.00 - - - 0.00
Purchase of Investments		 - - - - - - 0.00 - - - 2.89
Net Cash From Financing Activities		 -9.97 -25 -16 -16 25 -20 -16 -16 -15 -51 -6.44
Net Cash From Continuing Financing Activities		 -9.97 -25 -16 -16 25 -20 -16 -16 -15 -51 -6.44
Repayment of Debt		 -344 -181 -168 -168 -266 -291 -264 -278 -336 -260 -171
Repurchase of Common Equity		 -8.33 -15 -12 -11 -12 -7.81 -6.47 -17 -17 -17 -8.56
Payment of Dividends		 -1.26 -1.25 -1.23 -1.23 -1.22 -1.21 -1.20 -1.20 -1.18 -1.17 -1.15
Issuance of Debt		 343 172 168 165 303 280 259 279 339 227 176
Other Financing Activities, net		 -0.01 -0.01 -3.12 -1.09 -0.02 0.02 -2.63 -0.02 -0.02 -0.04 -1.73
Effect of Exchange Rate Changes		 -0.18 0.66 0.58 -0.42 -0.55 0.05 0.80 0.53 1.68 -0.21 -0.19
Cash Interest Paid		 0.63 0.78 0.74 0.82 1.22 1.45 1.06 1.11 1.04 0.79 0.64
Cash Income Taxes Paid		 5.40 5.11 3.80 4.27 4.08 4.46 2.91 4.18 5.36 4.30 3.16

Annual Balance Sheets for CTS

This table presents CTS's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 483 518 540 548 643 626 664 748 741 765 764
Total Current Assets		 246 216 234 239 237 233 289 326 319 242 253
Cash & Equivalents		 157 114 114 101 100 92 141 157 164 94 82
Accounts Receivable		 55 63 71 80 78 81 82 91 79 78 88
Inventories, net		 25 29 37 43 42 46 50 62 60 52 53
Other Current Assets		 9.86 11 13 15 17 15 16 16 17 18 29
Plant, Property, & Equipment, net		 70 82 88 99 105 97 97 97 93 94 90
Total Noncurrent Assets		 168 220 218 210 301 295 278 325 329 429 422
Goodwill		 34 62 71 71 106 109 110 152 158 201 210
Intangible Assets		 35 64 67 60 85 79 70 108 104 164 154
Noncurrent Deferred & Refundable Income Taxes		 64 46 21 22 20 24 25 23 25 28 25
Other Noncurrent Operating Assets		 1.34 1.74 2.10 2.04 28 26 24 42 42 36 34
Total Liabilities & Shareholders' Equity		 483 518 540 548 643 626 664 748 741 765 764
Total Liabilities		 202 200 196 170 238 202 201 242 214 237 213
Total Current Liabilities		 95 98 102 104 97 105 114 113 97 98 110
Accounts Payable		 40 40 49 52 48 50 56 53 43 43 48
Accrued Expenses		 47 46 41 37 36 38 37 35 35 35 37
Current Employee Benefit Liabilities		 7.15 11 12 15 9.56 13 18 20 15 16 21
Other Current Liabilities		 - - - 0.00 2.79 3.29 3.39 3.94 4.39 4.72 3.45
Total Noncurrent Liabilities		 107 102 93 66 141 97 87 130 117 139 103
Long-Term Debt		 91 89 76 50 100 55 50 84 68 92 58
Noncurrent Deferred & Payable Income Tax Liabilities		 - 2.37 3.80 3.99 5.64 7.01 5.89 16 15 13 13
Noncurrent Employee Benefit Liabilities		 - - - - 6.63 7.47 6.89 5.05 4.66 3.93 3.70
Other Noncurrent Operating Liabilities		 9.17 3.21 6.18 5.92 29 28 24 25 30 30 29
Commitments & Contingencies		 - - - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 282 318 344 378 405 424 464 506 527 528 552
Total Preferred & Common Equity		 282 318 344 378 405 424 464 506 527 528 552
Total Common Equity		 282 318 344 378 405 424 464 506 527 528 552
Common Stock		 342 343 346 350 352 353 357 363 364 367 368
Retained Earnings		 382 411 420 479 510 539 492 547 602 653 713
Treasury Stock		 -343 -343 -343 -353 -364 -373 -381 -403 -444 -487 -544
Accumulated Other Comprehensive Income / (Loss)		 -99 -93 -79 -98 -92 -96 -4.53 -0.67 4.26 -4.27 14

Quarterly Balance Sheets for CTS

This table presents CTS's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 735 747 756 754 733 726 790 766 785 790 777
Total Current Assets		 326 323 330 334 318 315 254 244 262 276 266
Cash & Equivalents		 148 144 151 160 162 161 0.00 90 99 110 91
Accounts Receivable		 97 98 98 90 81 85 86 81 86 86 94
Inventories, net		 63 63 63 65 58 52 56 54 57 54 57
Other Current Assets		 18 18 19 19 17 17 0.00 18 20 26 24
Plant, Property, & Equipment, net		 96 96 95 93 92 92 0.00 94 94 91 89
Total Noncurrent Assets		 312 328 331 327 323 319 196 428 429 424 422
Goodwill		 139 156 156 154 156 156 196 203 208 207 209
Intangible Assets		 106 110 109 104 100 97 0.00 162 162 157 149
Noncurrent Deferred & Refundable Income Taxes		 23 23 23 24 26 27 0.00 28 27 24 24
Other Noncurrent Operating Assets		 44 39 44 45 41 39 0.00 35 33 35 40
Total Liabilities & Shareholders' Equity		 735 747 756 754 733 726 790 766 785 790 777
Total Liabilities		 244 233 235 231 212 203 259 227 235 243 220
Total Current Liabilities		 122 106 107 103 96 92 105 92 100 105 105
Accounts Payable		 66 53 53 50 46 41 0.00 43 47 48 50
Accrued Expenses		 36 37 35 36 33 32 38 32 31 34 36
Current Employee Benefit Liabilities		 17 12 14 13 13 15 0.00 13 17 19 15
Other Current Liabilities		 3.53 4.03 4.29 4.44 4.40 4.37 0.00 4.34 4.56 3.59 4.10
Total Noncurrent Liabilities		 122 127 127 128 116 110 0.00 135 134 138 114
Long-Term Debt		 85 80 77 77 68 65 0.00 87 88 91 63
Noncurrent Deferred & Payable Income Tax Liabilities		 5.52 16 16 15 14 14 0.00 13 14 13 13
Noncurrent Employee Benefit Liabilities		 6.25 5.02 5.02 4.96 4.62 4.58 0.00 3.91 3.87 3.84 3.68
Other Noncurrent Operating Liabilities		 25 26 29 31 29 27 0.00 31 28 30 35
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 491 514 521 523 521 523 642 538 550 548 557
Total Preferred & Common Equity		 491 514 521 523 521 523 530 538 550 548 557
Total Common Equity		 491 514 521 523 521 523 642 538 550 548 557
Common Stock		 361 361 363 364 362 363 0.00 365 366 367 368
Retained Earnings		 533 564 575 588 612 626 642 665 682 695 730
Treasury Stock		 -395 -412 -420 -429 -456 -467 0.00 -493 -510 -527 -552
Accumulated Other Comprehensive Income / (Loss)		 -8.85 0.70 3.69 -0.68 2.94 0.78 0.00 1.27 12 13 12

Annual Metrics And Ratios for CTS

This table displays calculated financial ratios and metrics derived from CTS's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -5.37% 3.76% 6.63% 11.23% -0.32% -9.58% 20.95% 14.42% -6.21% -6.30% 5.16%
EBITDA Growth		 -52.18% 200.69% -18.24% 28.40% -6.28% -1.88% -143.94% 440.76% -7.89% -0.46% 21.14%
EBIT Growth		 -69.62% 404.76% -29.06% 37.93% -12.31% -6.79% -224.96% 236.90% -9.49% -3.63% 25.40%
NOPAT Growth		 -63.99% 269.28% -63.58% 253.79% -20.83% -11.06% 55.54% 28.19% -11.92% -1.76% 11.91%
Net Income Growth		 -73.78% 394.39% -57.98% 222.07% -22.32% -4.04% -220.70% 242.30% 1.61% -3.99% 17.75%
EPS Growth		 -73.08% 390.48% -58.25% 223.26% -21.58% -2.75% -222.64% 242.31% 3.78% -1.56% 20.99%
Operating Cash Flow Growth		 17.40% 20.56% 22.98% 0.18% 10.75% 19.22% 12.19% 40.70% -26.72% 11.80% 3.93%
Free Cash Flow Firm Growth		 -44.90% -262.45% 103.59% 1,837.25% -237.17% 234.90% 29.18% -88.58% 712.00% -160.23% 266.76%
Invested Capital Growth		 -6.45% 36.56% 4.20% 6.68% 23.76% -4.49% -3.72% 16.36% -0.59% 22.61% 0.16%
Revenue Q/Q Growth		 -1.82% 2.14% 2.25% 1.99% -1.06% 1.92% 1.89% 1.69% -3.10% 0.53% 1.84%
EBITDA Q/Q Growth		 -31.26% 18.35% -14.36% 25.71% -3.91% 9.89% -17.38% 6.66% -4.28% 2.25% 6.12%
EBIT Q/Q Growth		 -43.82% 27.40% -20.92% 37.73% -6.40% 15.55% -8.53% 7.40% -4.95% 1.79% 8.27%
NOPAT Q/Q Growth		 -62.63% 176.40% -62.87% 199.51% -17.62% 11.42% 1.73% 6.12% -2.16% 1.34% 4.01%
Net Income Q/Q Growth		 -70.57% 176.88% -60.28% 203.20% -17.19% 16.40% -16.03% 10.73% 0.63% -2.87% 9.25%
EPS Q/Q Growth		 -16.00% 45.07% -67.42% 215.91% -17.42% 15.22% -16.07% 11.45% 1.59% -2.58% 10.61%
Operating Cash Flow Q/Q Growth		 -7.06% -3.86% -3.42% 8.41% 14.34% 5.23% -1.67% -0.46% 8.04% -5.80% 3.30%
Free Cash Flow Firm Q/Q Growth		 -52.66% -5.31% -88.06% 328.84% -4.60% 7.19% 9.03% -49.41% 24.12% 7.04% 138.44%
Invested Capital Q/Q Growth		 -8.47% 2.21% -1.99% 1.41% -0.50% -0.52% -1.78% 1.12% -2.00% -2.02% -0.20%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 33.25% 35.40% 33.20% 35.06% 33.60% 32.79% 35.99% 35.87% 34.68% 36.67% 38.43%
EBITDA Margin		 6.70% 19.42% 14.89% 17.19% 16.16% 17.54% -6.37% 18.97% 18.63% 19.80% 22.26%
Operating Margin		 4.74% 15.92% 9.10% 12.97% 11.47% 10.64% 14.91% 15.85% 13.64% 14.11% 15.27%
EBIT Margin		 3.09% 15.04% 10.00% 12.40% 10.91% 11.25% -11.62% 13.90% 13.42% 13.80% 15.88%
Profit (Net Income) Margin		 1.82% 8.67% 3.42% 9.89% 7.71% 8.18% -8.16% 10.15% 11.00% 11.27% 12.07%
Tax Burden Percent		 56.72% 60.06% 35.89% 80.09% 71.91% 76.27% 68.77% 73.79% 80.55% 81.59% 77.97%
Interest Burden Percent		 103.77% 95.98% 95.13% 99.56% 98.22% 95.34% 102.13% 98.94% 101.75% 100.06% 97.47%
Effective Tax Rate		 43.28% 39.94% 64.11% 19.91% 28.09% 23.73% 0.00% 26.21% 19.46% 18.41% 22.03%
Return on Invested Capital (ROIC)		 4.61% 14.89% 4.60% 15.43% 10.58% 8.70% 14.11% 17.05% 14.00% 12.39% 12.24%
ROIC Less NNEP Spread (ROIC-NNEP)		 9.89% 22.80% 2.53% 20.76% 20.49% 7.29% 162.44% 28.04% 13.91% 14.95% 5.67%
Return on Net Nonoperating Assets (RNNOA)		 -2.18% -3.42% -0.23% -2.54% -1.35% -0.33% -23.55% -4.76% -2.28% -1.41% -0.14%
Return on Equity (ROE)		 2.43% 11.47% 4.37% 12.89% 9.23% 8.37% -9.44% 12.29% 11.72% 10.99% 12.10%
Cash Return on Invested Capital (CROIC)		 11.28% -16.02% 0.49% 8.97% -10.66% 13.29% 17.91% 1.93% 14.59% -7.92% 12.08%
Operating Return on Assets (OROA)		 2.51% 11.92% 8.00% 10.73% 8.59% 7.52% -9.24% 11.55% 9.92% 9.44% 11.24%
Return on Assets (ROA)		 1.48% 6.87% 2.73% 8.55% 6.07% 5.46% -6.49% 8.43% 8.13% 7.71% 8.54%
Return on Common Equity (ROCE)		 2.43% 11.47% 4.37% 12.89% 9.23% 8.37% -9.44% 12.29% 11.72% 10.99% 12.10%
Return on Equity Simple (ROE_SIMPLE)		 2.47% 10.82% 4.20% 12.31% 8.92% 8.19% -9.03% 11.77% 11.49% 10.95% 0.00%
Net Operating Profit after Tax (NOPAT)		 10 38 14 49 39 34 54 69 60 59 64
NOPAT Margin		 2.69% 9.56% 3.27% 10.39% 8.25% 8.12% 10.44% 11.69% 10.98% 11.51% 11.90%
Net Nonoperating Expense Percent (NNEP)		 -5.28% -7.91% 2.07% -5.33% -9.92% 1.42% -148.33% -10.99% 0.10% -2.55% 6.56%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 11.63% 10.17% 9.55% 10.58%
Cost of Revenue to Revenue		 66.75% 64.60% 66.80% 64.94% 66.40% 67.21% 64.01% 64.13% 65.33% 63.33% 61.57%
SG&A Expenses to Revenue		 15.59% 15.54% 17.01% 15.64% 15.01% 15.99% 16.10% 15.59% 15.23% 17.12% 18.24%
R&D to Revenue		 5.88% 6.06% 5.94% 5.38% 5.54% 5.73% 4.65% 4.11% 4.53% 4.53% 4.67%
Operating Expenses to Revenue		 28.51% 19.48% 24.10% 22.09% 22.12% 22.15% 21.08% 20.03% 21.04% 22.56% 23.16%
Earnings before Interest and Taxes (EBIT)		 12 60 42 58 51 48 -60 82 74 71 86
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 26 77 63 81 76 74 -33 111 103 102 120
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.95 2.22 2.39 2.21 2.36 2.58 2.53 2.47 2.58 2.99 2.26
Price to Tangible Book Value (P/TBV)		 2.58 3.68 3.99 3.38 4.48 4.65 4.13 5.08 5.12 9.50 6.60
Price to Revenue (P/Rev)		 1.44 1.78 1.94 1.77 2.04 2.58 2.28 2.13 2.47 3.08 2.30
Price to Earnings (P/E)		 78.97 20.54 56.87 17.93 26.50 31.49 0.00 20.95 22.44 27.33 19.07
Dividend Yield		 0.95% 0.74% 0.64% 0.63% 0.54% 0.59% 0.44% 0.41% 0.37% 0.30% 0.37%
Earnings Yield		 1.27% 4.87% 1.76% 5.58% 3.77% 3.18% 0.00% 4.77% 4.46% 3.66% 5.24%
Enterprise Value to Invested Capital (EV/IC)		 2.24 2.32 2.56 2.40 2.37 2.73 2.90 2.71 2.93 3.00 2.32
Enterprise Value to Revenue (EV/Rev)		 1.26 1.72 1.85 1.67 2.04 2.49 2.11 2.00 2.29 3.07 2.26
Enterprise Value to EBITDA (EV/EBITDA)		 18.85 8.86 12.45 9.69 12.63 14.18 0.00 10.55 12.30 15.52 10.13
Enterprise Value to EBIT (EV/EBIT)		 40.87 11.44 18.54 13.42 18.71 22.11 0.00 14.40 17.09 22.27 14.20
Enterprise Value to NOPAT (EV/NOPAT)		 47.01 17.99 56.77 16.03 24.74 30.65 20.18 17.12 20.88 26.69 18.94
Enterprise Value to Operating Cash Flow (EV/OCF)		 12.34 14.46 13.51 13.47 14.87 13.74 12.54 9.69 14.21 15.96 11.96
Enterprise Value to Free Cash Flow (EV/FCFF)		 19.22 0.00 534.72 27.57 0.00 20.06 15.91 151.43 20.04 0.00 19.19
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.32 0.28 0.22 0.13 0.25 0.13 0.11 0.17 0.13 0.17 0.10
Long-Term Debt to Equity		 0.32 0.28 0.22 0.13 0.25 0.13 0.11 0.17 0.13 0.17 0.10
Financial Leverage		 -0.22 -0.15 -0.09 -0.12 -0.07 -0.05 -0.15 -0.17 -0.16 -0.09 -0.02
Leverage Ratio		 1.65 1.67 1.60 1.51 1.52 1.53 1.45 1.46 1.44 1.43 1.42
Compound Leverage Factor		 1.71 1.60 1.52 1.50 1.49 1.46 1.49 1.44 1.47 1.43 1.38
Debt to Total Capital		 24.36% 22.09% 18.16% 11.68% 19.75% 11.42% 9.74% 14.18% 11.36% 14.67% 9.44%
Short-Term Debt to Total Capital		 0.00% 0.25% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 24.36% 21.84% 18.16% 11.68% 19.75% 11.42% 9.74% 14.18% 11.36% 14.67% 9.44%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 75.64% 77.91% 81.84% 88.32% 80.25% 88.58% 90.26% 85.82% 88.64% 85.33% 90.56%
Debt to EBITDA		 3.54 1.17 1.21 0.62 1.32 0.73 -1.53 0.75 0.66 0.89 0.48
Net Debt to EBITDA		 -2.59 -0.31 -0.59 -0.63 -0.01 -0.50 2.80 -0.66 -0.94 -0.03 -0.21
Long-Term Debt to EBITDA		 3.54 1.16 1.21 0.62 1.32 0.73 -1.53 0.75 0.66 0.89 0.48
Debt to NOPAT		 8.83 2.38 5.52 1.02 2.58 1.59 0.93 1.22 1.12 1.54 0.89
Net Debt to NOPAT		 -6.45 -0.62 -2.70 -1.04 -0.01 -1.08 -1.71 -1.07 -1.59 -0.05 -0.38
Long-Term Debt to NOPAT		 8.83 2.35 5.52 1.02 2.58 1.59 0.93 1.22 1.12 1.54 0.89
Altman Z-Score		 3.99 4.65 4.94 5.67 4.78 5.62 5.33 5.60 6.37 6.46 6.13
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.60 2.20 2.28 2.30 2.45 2.22 2.53 2.89 3.29 2.50 2.30
Quick Ratio		 2.24 1.80 1.80 1.74 1.84 1.65 1.96 2.20 2.50 1.76 1.55
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 25 -41 1.47 28 -39 53 68 7.76 63 -38 64
Operating Cash Flow to CapEx		 499.06% 575.35% 330.70% 204.15% 298.23% 516.78% 550.74% 845.58% 602.60% 532.55% 649.07%
Free Cash Flow to Firm to Interest Expense		 9.56 -11.03 0.44 13.63 -14.72 16.07 32.18 3.54 18.91 -8.96 14.76
Operating Cash Flow to Interest Expense		 14.90 12.75 17.36 27.89 24.32 23.47 40.81 55.29 26.66 23.44 23.70
Operating Cash Flow Less CapEx to Interest Expense		 11.91 10.53 12.11 14.23 16.17 18.93 33.40 48.75 22.24 19.04 20.05
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.81 0.79 0.80 0.86 0.79 0.67 0.79 0.83 0.74 0.68 0.71
Accounts Receivable Turnover		 6.86 6.77 6.35 6.27 5.95 5.33 6.29 6.78 6.49 6.60 6.53
Inventory Turnover		 9.72 9.62 8.66 7.63 7.27 6.47 6.88 6.73 5.88 5.75 6.34
Fixed Asset Turnover		 5.41 5.22 4.97 5.01 4.59 4.19 5.28 6.04 5.80 5.52 5.88
Accounts Payable Turnover		 6.10 6.38 6.33 6.04 6.22 5.77 6.19 6.92 7.44 7.58 7.34
Days Sales Outstanding (DSO)		 53.21 53.91 57.47 58.22 61.30 68.42 58.06 53.84 56.20 55.28 55.88
Days Inventory Outstanding (DIO)		 37.53 37.93 42.14 47.84 50.24 56.42 53.02 54.20 62.07 63.48 57.59
Days Payable Outstanding (DPO)		 59.81 57.22 57.64 60.44 58.72 63.21 58.94 52.74 49.09 48.12 49.75
Cash Conversion Cycle (CCC)		 30.93 34.61 41.97 45.62 52.82 61.63 52.14 55.30 69.19 70.63 63.72
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 215 294 307 327 405 387 372 433 430 528 527
Invested Capital Turnover		 1.72 1.56 1.41 1.49 1.28 1.07 1.35 1.46 1.28 1.08 1.03
Increase / (Decrease) in Invested Capital		 -15 79 12 20 78 -18 -14 61 -2.54 97 0.82
Enterprise Value (EV)		 483 682 784 783 957 1,055 1,081 1,175 1,262 1,585 1,221
Market Capitalization		 549 706 822 834 958 1,092 1,172 1,248 1,358 1,588 1,245
Book Value per Share		 $8.63 $9.70 $10.44 $11.42 $12.43 $13.13 $14.39 $15.88 $16.91 $17.63 $18.99
Tangible Book Value per Share		 $6.53 $5.85 $6.25 $7.46 $6.56 $7.28 $8.81 $7.71 $8.51 $5.55 $6.49
Total Capital		 372 408 420 428 505 478 514 590 594 622 609
Total Debt		 91 90 76 50 100 55 50 84 68 91 58
Total Long-Term Debt		 91 89 76 50 100 55 50 84 68 91 58
Net Debt		 -66 -24 -37 -51 -0.54 -37 -91 -73 -96 -3.08 -25
Capital Expenditures (CapEx)		 7.85 8.20 18 28 22 15 16 14 15 19 16
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -5.59 4.78 18 34 40 37 34 56 58 52 61
Debt-free Net Working Capital (DFNWC)		 151 119 131 135 141 128 175 213 222 147 143
Net Working Capital (NWC)		 151 118 131 135 141 128 175 213 222 147 143
Net Nonoperating Expense (NNE)		 3.32 3.56 -0.63 2.35 2.55 -0.27 95 9.05 -0.08 1.27 -0.88
Net Nonoperating Obligations (NNO)		 -66 -24 -37 -51 -0.54 -37 -91 -73 -96 -3.08 -25
Total Depreciation and Amortization (D&A)		 14 17 21 23 25 27 27 30 29 31 35
Debt-free, Cash-free Net Working Capital to Revenue		 -1.46% 1.20% 4.17% 7.32% 8.59% 8.61% 6.54% 9.60% 10.62% 10.16% 11.22%
Debt-free Net Working Capital to Revenue		 39.58% 29.89% 31.02% 28.77% 29.96% 30.25% 34.12% 36.33% 40.39% 28.45% 26.42%
Net Working Capital to Revenue		 39.58% 29.64% 31.02% 28.77% 29.96% 30.25% 34.12% 36.33% 40.39% 28.45% 26.42%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.21 $1.05 $0.44 $1.41 $1.11 $1.07 ($1.30) $1.86 $1.93 $1.91 $2.21
Adjusted Weighted Average Basic Shares Outstanding		 32.96M 32.73M 32.89M 33.02M 32.70M 32.32M 32.33M 31.97M 31.36M 30.41M 29.51M
Adjusted Diluted Earnings per Share		 $0.21 $1.03 $0.43 $1.39 $1.09 $1.06 ($1.30) $1.85 $1.92 $1.89 $2.19
Adjusted Weighted Average Diluted Shares Outstanding		 33.48M 33.25M 33.42M 33.57M 33.11M 32.58M 32.33M 32.24M 31.58M 30.72M 29.81M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 32.58M 32.76M 32.94M 32.73M 64.87M 32.35M 32.15M 31.67M 30.79M 30.04M 28.70M
Normalized Net Operating Profit after Tax (NOPAT)		 26 33 30 53 44 36 55 70 66 63 66
Normalized NOPAT Margin		 6.69% 8.29% 7.17% 11.25% 9.38% 8.45% 10.67% 11.93% 12.02% 12.26% 12.10%
Pre Tax Income Margin		 3.21% 14.43% 9.52% 12.35% 10.72% 10.72% -11.87% 13.76% 13.65% 13.81% 15.48%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 4.50 16.11 12.66 27.99 19.33 14.58 -28.24 37.23 22.17 16.80 19.95
NOPAT to Interest Expense		 3.91 10.25 4.13 23.44 14.61 10.52 25.36 31.31 18.15 14.02 14.95
EBIT Less CapEx to Interest Expense		 1.51 13.89 7.41 14.33 11.17 10.04 -35.65 30.69 17.75 12.40 16.30
NOPAT Less CapEx to Interest Expense		 0.92 8.03 -1.12 9.78 6.46 5.98 17.95 24.77 13.72 9.62 11.30
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 76.09% 15.22% 36.41% 11.36% 14.49% 14.93% -12.36% 8.61% 8.33% 8.41% 7.27%
Augmented Payout Ratio		 336.20% 15.22% 36.41% 31.64% 46.99% 38.23% -33.34% 44.61% 75.94% 81.70% 93.28%

Quarterly Metrics And Ratios for CTS

This table displays calculated financial ratios and metrics derived from CTS's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 28,695,710.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 28,695,710.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.60
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -11.43% -12.36% -13.87% -10.35% -1.58% 2.20% 0.02% 3.95% 8.00% 8.55% 10.70%
EBITDA Growth		 2.35% -15.94% -30.28% 6.08% 18.22% 9.27% 24.21% 30.81% -3.46% 39.30% 21.21%
EBIT Growth		 7.49% -18.53% -41.48% 8.44% 21.29% 7.40% 28.83% 36.83% -8.51% 57.13% 30.04%
NOPAT Growth		 -12.19% -9.19% -33.94% -0.55% 31.80% 5.49% 14.10% 24.63% -15.90% 31.94% 29.18%
Net Income Growth		 18.42% 2.54% -39.39% 14.03% 33.73% -11.19% 20.22% 25.97% -24.31% 70.70% 28.65%
EPS Growth		 18.92% 6.52% -37.93% 17.07% 38.64% -10.20% 22.22% 29.17% -22.03% 76.32% 34.09%
Operating Cash Flow Growth		 -63.34% 25.97% 63.70% -16.19% 59.91% -19.07% -15.25% 44.44% -18.00% 17.28% 11.45%
Free Cash Flow Firm Growth		 107.45% 136.78% 225.78% -21.35% -3,330.92% -594.52% -360.88% -362.59% -236.58% 120.86% 124.23%
Invested Capital Growth		 2.58% -0.59% -5.43% -4.70% 22.63% 22.61% 25.40% 26.31% 75.66% 0.16% -1.03%
Revenue Q/Q Growth		 -7.32% -7.33% 0.85% 3.51% 1.74% -3.77% -1.31% 7.59% 5.66% -3.99% 1.43%
EBITDA Q/Q Growth		 12.78% -7.05% -15.70% 20.05% 25.67% -14.08% -4.18% 26.43% -9.06% 16.67% -9.64%
EBIT Q/Q Growth		 18.68% -9.96% -22.70% 31.27% 32.75% -20.28% -7.27% 39.42% -13.57% 24.80% -13.53%
NOPAT Q/Q Growth		 -8.26% 4.18% -16.24% 24.24% 21.57% -16.62% -9.40% 35.72% -20.70% 23.51% -2.82%
Net Income Q/Q Growth		 8.33% 9.66% -27.42% 32.27% 27.03% -27.18% -1.75% 38.60% -26.12% 44.20% -12.86%
EPS Q/Q Growth		 7.32% 11.36% -26.53% 33.33% 27.08% -27.87% 0.00% 40.91% -25.81% 45.65% -11.94%
Operating Cash Flow Q/Q Growth		 -5.49% 44.88% -42.90% 7.20% 80.32% -26.67% -40.21% 82.70% 2.37% 0.65% -40.79%
Free Cash Flow Firm Q/Q Growth		 -94.45% 560.41% 118.01% -1.59% -328.04% -1.08% -15.01% 0.95% -126.77% 108.05% 34.07%
Invested Capital Q/Q Growth		 -1.86% -2.00% -0.95% 0.03% 26.29% -2.02% 1.30% 0.76% -1.98% -0.20% 0.40%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 34.49% 33.73% 35.86% 35.63% 37.60% 37.59% 37.01% 38.75% 38.71% 39.12% 39.49%
EBITDA Margin		 19.35% 19.40% 16.22% 18.81% 23.24% 20.75% 20.14% 23.67% 20.37% 24.76% 22.06%
Operating Margin		 13.52% 13.04% 11.56% 13.65% 16.22% 14.91% 12.95% 16.80% 14.65% 16.53% 15.79%
EBIT Margin		 13.96% 13.56% 10.40% 13.18% 17.20% 14.25% 13.39% 17.35% 14.20% 18.45% 15.73%
Profit (Net Income) Margin		 10.38% 12.29% 8.84% 11.30% 14.11% 10.68% 10.63% 13.69% 9.57% 14.38% 12.35%
Tax Burden Percent		 74.56% 86.91% 81.41% 82.77% 83.23% 78.42% 82.91% 80.62% 69.41% 79.11% 79.35%
Interest Burden Percent		 99.76% 104.23% 104.47% 103.54% 98.53% 95.52% 95.73% 97.87% 97.17% 98.50% 98.96%
Effective Tax Rate		 25.44% 13.09% 18.59% 17.23% 16.77% 21.58% 17.09% 19.38% 30.59% 20.89% 20.65%
Return on Invested Capital (ROIC)		 13.20% 14.45% 11.38% 13.32% 14.16% 12.59% 11.52% 14.62% 13.04% 13.44% 13.07%
ROIC Less NNEP Spread (ROIC-NNEP)		 12.64% 13.04% 12.28% 13.31% 12.02% 15.20% 11.80% 14.24% 13.51% 0.12% 14.60%
Return on Net Nonoperating Assets (RNNOA)		 -1.82% -2.14% -1.88% -2.17% -0.86% -1.43% -1.10% -1.43% -4.10% 0.00% -0.43%
Return on Equity (ROE)		 11.38% 12.30% 9.50% 11.15% 13.30% 11.16% 10.43% 13.19% 8.94% 13.44% 12.64%
Cash Return on Invested Capital (CROIC)		 11.70% 14.59% 17.98% 17.23% -8.35% -7.92% -9.83% -9.85% -39.94% 12.08% 13.90%
Operating Return on Assets (OROA)		 10.65% 10.02% 7.45% 9.17% 11.44% 9.75% 9.22% 11.97% 9.55% 13.06% 11.31%
Return on Assets (ROA)		 7.92% 9.08% 6.34% 7.86% 9.38% 7.31% 7.32% 9.45% 6.44% 10.18% 8.88%
Return on Common Equity (ROCE)		 11.38% 12.30% 9.50% 11.15% 13.30% 11.16% 10.43% 13.19% 8.94% 13.44% 12.64%
Return on Equity Simple (ROE_SIMPLE)		 11.51% 0.00% 10.23% 10.54% 11.27% 0.00% 11.21% 11.67% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 14 14 12 15 18 15 14 18 15 18 17
NOPAT Margin		 10.08% 11.33% 9.41% 11.30% 13.50% 11.70% 10.74% 13.54% 10.16% 13.08% 12.53%
Net Nonoperating Expense Percent (NNEP)		 0.56% 1.41% -0.90% 0.00% 2.14% -2.61% -0.27% 0.38% -0.47% 13.32% -1.54%
Return On Investment Capital (ROIC_SIMPLE)		 - 2.38% 2.01% - - 2.40% 2.16% 2.87% 2.28% 2.95% 2.81%
Cost of Revenue to Revenue		 65.51% 66.27% 64.14% 64.37% 62.40% 62.41% 62.99% 61.25% 61.29% 60.88% 60.51%
SG&A Expenses to Revenue		 13.87% 15.62% 17.70% 16.39% 17.00% 17.41% 18.78% 17.06% 19.04% 18.07% 18.66%
R&D to Revenue		 4.70% 4.24% 5.25% 4.68% 3.80% 4.45% 4.92% 4.68% 4.83% 4.26% 4.76%
Operating Expenses to Revenue		 20.97% 20.70% 24.30% 21.98% 21.38% 22.67% 24.06% 21.95% 24.06% 22.60% 23.70%
Earnings before Interest and Taxes (EBIT)		 19 17 13 17 23 18 17 23 20 25 22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 26 24 20 24 31 26 25 32 29 34 31
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.50 2.58 2.79 2.96 2.77 2.99 2.32 2.31 2.15 2.26 2.46
Price to Tangible Book Value (P/TBV)		 4.93 5.12 5.48 5.74 9.47 9.50 7.22 7.03 6.43 6.60 6.85
Price to Revenue (P/Rev)		 2.30 2.47 2.74 3.00 2.86 3.08 2.42 2.44 2.22 2.30 2.47
Price to Earnings (P/E)		 21.68 22.44 27.26 28.08 24.55 27.33 20.68 19.81 19.69 19.07 19.82
Dividend Yield		 0.38% 0.37% 0.34% 0.32% 0.33% 0.30% 0.39% 0.38% 0.40% 0.37% 0.34%
Earnings Yield		 4.61% 4.46% 3.67% 3.56% 4.07% 3.66% 4.84% 5.05% 5.08% 5.24% 5.05%
Enterprise Value to Invested Capital (EV/IC)		 2.78 2.93 3.19 3.40 2.74 3.00 2.33 2.34 2.19 2.32 2.54
Enterprise Value to Revenue (EV/Rev)		 2.15 2.29 2.56 2.82 2.88 3.07 2.41 2.42 2.18 2.26 2.42
Enterprise Value to EBITDA (EV/EBITDA)		 11.39 12.30 14.49 15.26 14.79 15.52 11.63 11.00 10.20 10.13 10.66
Enterprise Value to EBIT (EV/EBIT)		 15.71 17.09 21.03 22.02 21.12 22.27 16.61 15.51 14.58 14.20 14.75
Enterprise Value to NOPAT (EV/NOPAT)		 19.76 20.88 24.98 26.75 25.20 26.69 20.39 19.49 18.69 18.94 19.63
Enterprise Value to Operating Cash Flow (EV/OCF)		 14.85 14.21 14.16 15.75 14.01 15.96 12.90 11.98 11.71 11.96 12.92
Enterprise Value to Free Cash Flow (EV/FCFF)		 24.06 20.04 17.22 19.27 0.00 0.00 0.00 0.00 0.00 19.19 18.16
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.15 0.13 0.13 0.12 0.19 0.17 0.16 0.16 0.17 0.10 0.11
Long-Term Debt to Equity		 0.15 0.13 0.13 0.12 0.19 0.17 0.16 0.16 0.17 0.10 0.11
Financial Leverage		 -0.14 -0.16 -0.15 -0.16 -0.07 -0.09 -0.09 -0.10 -0.30 -0.02 -0.03
Leverage Ratio		 1.47 1.44 1.43 1.42 1.47 1.43 1.41 1.41 1.33 1.42 1.41
Compound Leverage Factor		 1.47 1.50 1.49 1.47 1.44 1.36 1.35 1.38 1.29 1.40 1.39
Debt to Total Capital		 12.79% 11.36% 11.46% 11.06% 16.21% 14.67% 13.87% 13.79% 14.21% 9.44% 10.08%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 12.79% 11.36% 11.46% 11.06% 16.21% 14.67% 13.87% 13.79% 14.21% 9.44% 10.08%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 87.21% 88.64% 88.54% 88.94% 83.79% 85.33% 86.13% 86.21% 85.79% 90.56% 89.92%
Debt to EBITDA		 0.72 0.66 0.72 0.68 1.03 0.89 0.81 0.77 0.80 0.48 0.50
Net Debt to EBITDA		 -0.78 -0.94 -1.01 -1.01 0.08 -0.03 -0.03 -0.10 -0.17 -0.21 -0.23
Long-Term Debt to EBITDA		 0.72 0.66 0.72 0.68 1.03 0.89 0.81 0.77 0.80 0.48 0.50
Debt to NOPAT		 1.24 1.12 1.24 1.20 1.75 1.54 1.42 1.36 1.46 0.89 0.91
Net Debt to NOPAT		 -1.35 -1.59 -1.75 -1.77 0.13 -0.05 -0.06 -0.18 -0.32 -0.38 -0.41
Long-Term Debt to NOPAT		 1.24 1.12 1.24 1.20 1.75 1.54 1.42 1.36 1.46 0.89 0.91
Altman Z-Score		 5.68 6.12 6.44 6.94 5.53 6.23 5.49 5.48 5.16 5.87 6.11
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.23 3.29 3.32 3.41 2.46 2.50 2.63 2.61 2.64 2.30 2.52
Quick Ratio		 2.41 2.50 2.53 2.67 1.75 1.76 1.86 1.84 1.87 1.55 1.75
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 2.52 17 36 36 -82 -82 -95 -94 -213 17 23
Operating Cash Flow to CapEx		 805.20% 915.73% 453.80% 423.31% 914.36% 425.41% 347.55% 864.39% 605.02% 916.02% 346.11%
Free Cash Flow to Firm to Interest Expense		 2.53 20.28 45.36 42.92 -62.38 -63.64 -81.22 -83.75 -191.81 18.81 32.44
Operating Cash Flow to Interest Expense		 22.20 39.01 22.86 23.56 27.08 20.04 13.30 25.29 26.15 32.07 24.43
Operating Cash Flow Less CapEx to Interest Expense		 19.44 34.75 17.82 18.00 24.12 15.33 9.47 22.37 21.83 28.57 17.37
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.76 0.74 0.72 0.70 0.66 0.68 0.69 0.69 0.67 0.71 0.72
Accounts Receivable Turnover		 6.09 6.49 5.94 5.63 5.83 6.60 6.36 6.09 6.17 6.53 6.33
Inventory Turnover		 5.72 5.88 5.71 5.87 5.38 5.75 5.82 5.96 5.96 6.34 6.09
Fixed Asset Turnover		 6.02 5.80 5.64 5.52 5.51 5.52 5.56 5.62 0.00 5.88 6.06
Accounts Payable Turnover		 6.37 7.44 6.99 7.13 6.96 7.58 7.32 7.36 0.00 7.34 7.24
Days Sales Outstanding (DSO)		 59.94 56.20 61.40 64.79 62.58 55.28 57.36 59.89 59.13 55.88 57.64
Days Inventory Outstanding (DIO)		 63.86 62.07 63.98 62.18 67.90 63.48 62.67 61.22 61.23 57.59 59.96
Days Payable Outstanding (DPO)		 57.26 49.09 52.25 51.16 52.47 48.12 49.83 49.60 0.00 49.75 50.44
Cash Conversion Cycle (CCC)		 66.54 69.19 73.13 75.81 78.00 70.63 70.19 71.51 120.37 63.72 67.15
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 439 430 426 427 539 528 535 539 528 527 529
Invested Capital Turnover		 1.31 1.28 1.21 1.18 1.05 1.08 1.07 1.08 1.28 1.03 1.04
Increase / (Decrease) in Invested Capital		 11 -2.54 -25 -21 99 97 108 112 227 0.82 -5.53
Enterprise Value (EV)		 1,221 1,262 1,358 1,451 1,477 1,585 1,245 1,260 1,158 1,221 1,342
Market Capitalization		 1,304 1,358 1,453 1,548 1,469 1,588 1,248 1,272 1,177 1,245 1,371
Book Value per Share		 $16.67 $16.91 $16.96 $17.10 $17.48 $17.63 $17.92 $18.43 $18.58 $18.99 $19.43
Tangible Book Value per Share		 $8.44 $8.51 $8.62 $8.83 $5.11 $5.55 $5.76 $6.06 $6.21 $6.49 $6.98
Total Capital		 599 594 589 588 634 622 625 638 638 609 620
Total Debt		 77 68 68 65 103 91 87 88 91 58 63
Total Long-Term Debt		 77 68 68 65 103 91 87 88 91 58 63
Net Debt		 -83 -96 -95 -96 7.83 -3.08 -3.59 -11 -20 -25 -28
Capital Expenditures (CapEx)		 2.75 3.50 4.04 4.64 3.87 6.10 4.47 3.28 4.80 3.19 5.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 71 58 60 61 57 52 61 62 61 61 70
Debt-free Net Working Capital (DFNWC)		 231 222 222 222 152 147 151 161 171 143 161
Net Working Capital (NWC)		 231 222 222 222 152 147 151 161 171 143 161
Net Nonoperating Expense (NNE)		 -0.41 -1.19 0.71 -0.00 -0.81 1.30 0.14 -0.20 0.85 -1.79 0.25
Net Nonoperating Obligations (NNO)		 -83 -96 -95 -96 7.83 -3.08 -3.59 -11 -20 -25 -28
Total Depreciation and Amortization (D&A)		 7.25 7.29 7.33 7.33 7.99 8.28 8.49 8.55 8.84 8.66 8.81
Debt-free, Cash-free Net Working Capital to Revenue		 12.46% 10.62% 11.29% 11.87% 11.09% 10.16% 11.79% 11.87% 11.50% 11.22% 12.57%
Debt-free Net Working Capital to Revenue		 40.65% 40.39% 41.92% 43.17% 29.58% 28.45% 29.30% 30.96% 32.25% 26.42% 28.95%
Net Working Capital to Revenue		 40.65% 40.39% 41.92% 43.17% 29.58% 28.45% 29.30% 30.96% 32.25% 26.42% 28.95%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.45 $0.49 $0.36 $0.48 $0.62 $0.45 $0.45 $0.62 $0.47 $0.67 $0.60
Adjusted Weighted Average Basic Shares Outstanding		 31.30M 31.36M 30.74M 30.51M 30.30M 30.41M 30.01M 29.74M 29.35M 29.51M 28.69M
Adjusted Diluted Earnings per Share		 $0.44 $0.49 $0.36 $0.48 $0.61 $0.44 $0.44 $0.62 $0.46 $0.67 $0.59
Adjusted Weighted Average Diluted Shares Outstanding		 31.51M 31.58M 30.99M 30.73M 30.54M 30.72M 30.33M 29.99M 29.63M 29.81M 29.00M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 31.16M 30.79M 30.57M 30.37M 30.12M 30.04M 29.84M 29.48M 29.05M 28.70M 28.59M
Normalized Net Operating Profit after Tax (NOPAT)		 16 15 13 16 19 16 14 19 15 18 18
Normalized NOPAT Margin		 11.87% 12.06% 10.51% 12.05% 13.98% 12.34% 11.03% 13.72% 10.30% 13.29% 12.75%
Pre Tax Income Margin		 13.93% 14.14% 10.86% 13.65% 16.95% 13.61% 12.82% 16.98% 13.79% 18.17% 15.57%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 18.84 20.57 16.32 20.60 17.43 14.02 14.43 20.95 18.28 27.80 30.93
NOPAT to Interest Expense		 13.60 17.19 14.77 17.65 13.68 11.51 11.57 16.35 13.09 19.70 24.64
EBIT Less CapEx to Interest Expense		 16.08 16.31 11.28 15.03 14.47 9.31 10.61 18.02 13.96 24.30 23.88
NOPAT Less CapEx to Interest Expense		 10.85 12.93 9.74 12.08 10.71 6.80 7.74 13.42 8.77 16.20 17.58
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 8.43% 8.33% 9.38% 9.01% 8.23% 8.41% 8.04% 7.52% 8.01% 7.27% 6.80%
Augmented Payout Ratio		 64.77% 75.94% 92.08% 92.93% 91.51% 81.70% 69.51% 74.05% 87.22% 93.28% 91.07%

Financials Breakdown Chart

Key Financial Trends

CTS Corp (NYSE: CTS) has shown stronger quarterly results in 2025 versus the prior year, with improving margins, higher revenue, and cash flow stability. Below are the key trend points drawn from the last four years of CTS’s quarterly statements, focused on what retail investors should watch.

  • Revenue and growth: Q4 2025 revenue reached 137.27 million, up from 125.77 million in Q4 2024 (about a 9% year‑over‑year increase). The trend across 2023–2025 shows CTS sustaining a multi‑year revenue trajectory.
  • Gross margin expansion: Q4 2025 gross margin was about 39.1% (53.71 million gross profit on 137.27 million revenue) versus roughly 37.0% in Q4 2024, indicating improved leverage on cost of goods sold.
  • Operating income improvement: Q4 2025 operating income rose to about 22.69 million from about 16.26 million in Q4 2024, signaling better operating leverage and cost control.
  • Earnings growth per share: Net income attributable to common shareholders increased to about 19.74 million in Q4 2025, with basic and diluted EPS at 0.67 USD, up from 0.45 USD (roughly) in Q4 2024, reflecting stronger profitability per share.
  • Cash flow from operations: Q4 2025 cash from continuing operating activities was about 29.21 million, up from 25.95 million in Q4 2024, signaling improving cash generation to support dividends and capital needs.
  • Constant per‑share dividend: Cash dividends to common per share remained at 0.04 USD, providing consistent income for shareholders without a dividend cut, which is a neutral-to-slightly-positive sign for income investors.
  • Share count and equity position: Weighted average shares outstanding remained in the mid‑20s to low‑30s millions range across recent quarters (roughly 29–31 million), implying stable dilution dynamics and predictable EPS comparisons over time.
  • Debt financing activity: CTS supplemented liquidity with sizable debt issuances in 2025 (e.g., 339.1 million issuance in Q3 2025 and 227.2 million issuance in Q4 2025). This increases leverage and future interest expense, a point of concern if revenue growth slows.
  • Net financing cash flow: In Q4 2025 CTS recorded a net cash outflow from financing activities (approximately -51.0 million), reflecting repayments, debt issuance timing, and other financing moves that weighed on near‑term cash balance despite strong operating cash flow.
05/08/26 03:55 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About CTS's Financials

When does CTS's financial year end?

According to the most recent income statement we have on file, CTS's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has CTS's net income changed over the last 10 years?

CTS's net income appears to be on an upward trend, with a most recent value of $65.32 million in 2025, rising from $6.95 million in 2015. The previous period was $55.47 million in 2024. Check out CTS's forecast to explore projected trends and price targets.

What is CTS's operating income?
CTS's total operating income in 2025 was $82.64 million, based on the following breakdown:
  • Total Gross Profit: $208.03 million
  • Total Operating Expenses: $125.38 million
How has CTS's revenue changed over the last 10 years?

Over the last 10 years, CTS's total revenue changed from $382.31 million in 2015 to $541.32 million in 2025, a change of 41.6%.

How much debt does CTS have?

CTS's total liabilities were at $212.53 million at the end of 2025, a 10.4% decrease from 2024, and a 5.4% increase since 2015.

How much cash does CTS have?

In the past 10 years, CTS's cash and equivalents has ranged from $82.30 million in 2025 to $163.88 million in 2023, and is currently $82.30 million as of their latest financial filing in 2025.

How has CTS's book value per share changed over the last 10 years?

Over the last 10 years, CTS's book value per share changed from 8.63 in 2015 to 18.99 in 2025, a change of 120.1%.


Related Companies

Financial statements for NYSE:CTS last updated on 5/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Massive Data Leak Exposes 512,000-Line Code That Could Change Society Forever
"You won't believe what I discovered at 4 World Trade Center" When our financial media correspondent travel...
Chaikin Analytics | Sponsoredtc pixel
Why I flew on a tiny helicopter next to a potential nuclear bomb target
Satellite Confirms: Elon Musk Activating Strange 'Dark Energy' Across U.S. South Confirmed by satellites 30...
Altimetry | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Elon’s AI supercomputer just went live. Here’s my #1 stock.
Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...
InvestorPlace | Sponsoredtc pixel
Is the SpaceX IPO “Rigged?”
The SpaceX IPO filing is official, with 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - pre...
The Oxford Club | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel